PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 153-159

  Nelissen, Inge ^a   Fiten, Pierre ^a   Vandenbroeck, Koen ^a   Hillert, Jan ^b   Olsson, Tomas ^b   Marrosu, Maria Giovanna ^c   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Association; Microsatellite; Multiple sclerosis; Myeloperoxidase; Platelet endothelial cell adhesion molecule 1; Single nucleotide polymorphism

Indexed keywords

CD31 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MICROSATELLITE DNA; MYELOPEROXIDASE;

ADULT; ARTICLE; CHROMOSOME 17Q; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADULT; AGE OF ONSET; ALLELES; ANTIGENS, CD31; BASE SEQUENCE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 17; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; ITALY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIPLE SCLEROSIS; PEROXIDASE; PHENOTYPE; PHYSICAL CHROMOSOME MAPPING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); REPRODUCIBILITY OF RESULTS; SWEDEN;

EID: 0034255711     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00293-9     Document Type: Article

References (34)

1. Chataway, J., Feakes, R., Coraddu, F., Gray, J., Deans, J., Fraser, M., Robertson, N., Broadley, S., Jones, H., Clayton, D., Goodfellow, P., Sawcer, S., Compston, A., 1998. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121, 1869-1887.
2. Chataway, J., Sawcer, S., Feakes, R., Coraddu, F., Broadley, S., Jones, H.B., Clayton, D., Gray, J., Goodfellow, P.N., Compston, A., 1999. A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. J. Neuroimmunol. 98, 208-213.
3. Cuzner, M.L., Opdenakker, G., 1999. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94, 1-14.
4. Duncan, G.S., Andrew, D.P., Takimoto, H., Kaufman, S.A., Yoshida, H., Spellberg, J., de la Pompa, J.L., Elia, A., Wakeman, A., Karan-Tamir, B., Muller, W.A., Senaldi, G., Zukowski, M.M., Mak, T.W., 1999. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162, 3022-3030.
5. Ebers, G.C., Bulman, D.E., Sadovnick, A.D., Paty, D.W., Warren, S., Hader, W, Murray, T.J., Seland, T.P., Duquette, P., Grey, T., Nelson, R., Nicolle, M., Brunet, D., 1986. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315, 1638-1642.
6. Ebers, G.C., Kukay, K., Bulman, D.E., Sadovnick, A.D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R.B., Hader, W., Paty, D.W., Hashimoto, S., Oger, J., Duquette, P., Warren, S., Gray, T., O'Connor, P., Nath, A., Auty, A., Metz, L., Francis, G., Paulseth, J.E., Murray, T.J., Pryse-Phillips, W., Nelson, R., Freedman, M., Brunet, D., Bouchard, J.P., Hinds, D., Risch, N., 1996. A full genome search in multiple sclerosis. Nat. Genet 13, 472-476.
7. Epplen, C., Jackel, S., Santos, E.J., D'Souza, M., Poehlau, D., Dolzauer, B., Sindern, E., Haupts, M., Rude, K.P., Weber, F., Stover, J., Poser, S., Gehler, W., Malin, J.P., Przuntek, H., Epplen, J.T., 1997. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann. Neurol. 41, 341-352.
8. Fiten, P., Vandenbroeck, K., Dubois, B., Van Coillie, E., Nelissen, I., Van Damme, J., Ligers, A., Hillert, J., Andersson, M., Olsson, T., Opdenakker, G., 1999. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. J. Neuroimmunol. 95, 195-201.
9. The American-French Multiple Sclerosis Genetic Group, Fontaine, B., Cournu, I., Arnaud, I., Babron, M.-C., Eichenbaum-Voline, S., Oksenberg, J.R., Pericak-Vance, M.A., Haines, J.L., Semama, G., Liblau, R., Lyon-Caen, O., Clerget-Darpoux, F., Clanet, M., Hauser, S.L., 1999. Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. Genes and Immunity 1, 149-150.
10. The Multiple Sclerosis Genetics Group, Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., Kim, D.J., Terwedow, H., Pericak-Vance, M.A., Rimmler, J.B., Haynes, C.S., Roses, A.D., Lee, A., Shaner, B., Menold, M., Seboun, E., Fitoussi, R.P., Gartioux, C., Reyes, C., Ribierre, F., Gyapay, G., Weissenbach, J., Hauser, S.L., Goodkin, D.E., Lincoln, R., Usuku, K., Garcia-Merino, A., Gatto, N., Young, S., Oksenberg, J.R., 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat. Genet. 13, 469-471.
11. He, B., Xu, C., Yang, B., Landtblom, A.M., Frednkson, S., Hillert, J., 1998. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J. Neuroimmunol. 86, 13-19.
12. Hillert, J., Olerup, O., 1993. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype. Neurology 43, 163-168.
13. Johnson, K., Gemperlein, I., Hudson, S., Shane, S., Rovera, G., 1989. Complete nucleotide sequence of the human myeloperoxidase gene. Nucleic Acids Res. 17, 7985-7986.
14. Kuokkanen, S., Gschwend, M., Rioux, J.D., Daly, M.J., Terwilliger, J.D., Tienari, P.J., Wikstrom, J., Palo, J., Stein, L.D., Hudson, T.J., Lander, E.S., Peltonen, L., 1997. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61, 1379-1387.
15. Losy, J., Niezgoda, A., Wender, M., 1999. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J. Neuroimmunol. 99, 169-172.
16. Marrosu, M.G., Murru, M.R., Costa, G., Murru, R., Muntoni, F., Cucca, F., 1998. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Gen. 7, 1235-1237.
17. Mycko, M.P., Kwinkowski, M., Tronczynska, E., Szymanska, B., Selmaj, K.W., 1998. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann. Neurol. 44, 70-75.
18. Nagra, R.M., Becher, B., Tourtellotte, W.W., Antel, J.P., Gold, D., Paladino, T., Smith, R.A., Nelson, J.R., Reynolds, W.F., 1997. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78, 97-107.
19. Newman, P.J., 1997. The biology of PECAM-1. J. Clin. Invest. 99, 3-8.
20. Newman, P.J., Berndt, M.C., Gorski, J., White, II G.C., Lyman, S., Paddock, C., Muller, W.A., 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219-1222.
21. Opdenakker, G., Van Damme, J., 1994. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today 15, 103-107.
22. Piedrafita, F.J., Molander, R.B., Vansant, G., Orlova, E.A., Pfahl, M., Reynolds, W.F., 1996. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271, 14412-14420.
23. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H., Tourtellotte, W.W., 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
24. Reynolds, W.F., Chang, E., Douer, D., Ball, E.D., Kanda, V., 1997. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90, 2730-2737.
25. Sawcer, S., Jones, H.B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P.N., Compston, A., 1996. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13, 464-468.
26. Schaid, D.J., 1996. General score tests for associations of genetic markers with disease using cases and their parents. Genet. Epidemiol. 13, 423-449.
27. Solberg, R., Sandberg, M., Natarajan, V., Torjesen, P.A., Hansson, V., Jahnsen, T., Tasken, K., 1997. The human gene for the regulatory subunit Rice of cyclic adenosine 3′, 5′-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids. Endocrinology 138, 169-181.
28. Spielman, R.S., McGinnis, R.E., Ewens, W.J., 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506-516.
29. Tienari, P.J., Wikstrom, J., Sajantila, A., Palo, J., Peltonen, L., 1992. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 340, 987-991.
30. Vandenbroeck, K., Opdenakker, G., Goris, A., Murru, R., Billiau, A., Marrosu, M.G., 1998. Interferon-γ gene polymorphism-associated risk for multiple sclerosis in Sardinia. Ann. Neurol. 44, 841-842.
31. Williams, K.C., Zhao, R.W., Ueno, K., Hickey, W.F., 1996. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat. J. Neurosci. Res. 45, 747-757.
32. Wong, D., Dorovini-Zis, K., 1996. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) expression by human brain microvessel endothelial cells in primary culture. Brain Res. 731, 217-220.
33. Wong, D., Prameya, R., Dorovini-Zis, K., 1999. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58, 138-152.
34. Woolf, B., 1955. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19, 251-253.